Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Bone densitometers are devices used to measure bone mineral density with techniques such as Dual-Energy X-ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT), Radiographic Absorptiometry (RA) and Quantitative Ultrasound (QUS). GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone densitometers market in Canada. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the bone densitometers market in Canada was Diagnostic Medical Systems followed by GE HealthCare Technologies, Hologic and Swissray Medical.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Dual-Energy X-ray Absorptiometry (DEXA) and Quantitative Ultrasound (QUS) are tracked under this category. Dual-Energy X-ray Absorptiometry (DEXA) has two different X-ray beams to estimate bone density in spine and hip. Quantitative ultrasound (QUS) measures the bone density through high frequency sound waves.

The bone densitometers market in Canada can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size bone densitometers in Canada, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.